Full Text (PDF)
Indian Journal of Cancer Education and Research 13(2):p 89-92, July-Dec 2025. | DOI: https://doi.org/10.21088/ijcer.2321.9815.13225.6
Case Report
Advanced Adenoid Cystic Carcinoma with Widespread Visceral and Skeletal Metastases
Virendra Bhandari, Pradumn Mishra, Rishabh Mahajan, Nayantara Pitaliya, Ashar Iqbal Lodi, Sagun Sagar Bajpai
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Indian Journal of Cancer Education and Research 13(2):p 89-92, July-Dec 2025. | DOI: https://doi.org/10.21088/ijcer.2321.9815.13225.6
How Cite This Article:
Pradumn Mishra, Rishabh Mahajan, Nayantara Pitaliya, et al. Advanced Adenoid Cystic Carcinoma with Widespread Visceral and Skeletal Metastases. Ind J Canc Educ Res 2025; 13(2): 89-92.Timeline
Received : August 28, 2025
Accepted : October 29, 2025
Published : December 30, 2025
Abstract
Context: Adenoid cystic carcinoma (ACC) is a rare malignancy of secretory glands, characterized by an indolent yet relentless course with high rates of local recurrence and distant metastases. Case: We present a case of a 40-year-old male diagnosed in 2019 with nasal ACC, who developed widespread metastases to lungs, liver, bones, peritoneum, and lymph nodes despite multiple surgeries and targeted therapies. Progression continued on lenvatinib, lenalidomide, and axitinib. Patient received palliative radiotherapy for painful skeletal lesions. Conclusion: This case highlights the aggressive nature of ACC in advanced stages and underscores the role of palliation when systemic therapies fail.
References
- 1. Coca-Pelaz A., Rodrigo J.P., Bradley P.J., et al. Adenoid cystic carcinoma of the head and neck—An update. Oral Oncol. 2015; 51(7): 652–661.
- 2. Laurie S.A., Ho A.L., Fury M.G., Sherman E., Pfister D.G. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma: A systematic review. Lancet Oncol. 2011; 12(8): 815–824.
- 3. Dillon P.M., Chakraborty S., Moskaluk C.A., Joshi P.J., Thomas C.Y. Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials. Head Neck. 2016 Apr; 38(4): 620–627. doi:10.1002/ hed.23925.
- 4. Tchekmedyian V., Sherman E.J., Palmer F, et al. Phase II study of Lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma. Head Neck. 2020 Apr; 42(4): 800–807. doi:10.1002/hed.26030.
- 5. Lui T., Saade R., Zielinski M.D., et al. Aggressive adenoid cystic carcinoma with unusual visceral metastasis. Curr Oncol. 2018 Aug; 25(4): e292– e297. doi:10.3747/co.25.4258.
- 6. Airoldi M., Pedani F., Succo G., et al. Doxorubicin-based chemotherapy for adenoid cystic carcinoma of the head and neck: a clinical experience. Anticancer Drugs. 2018 May; 29(5): 489–493. doi:10.1097/CAD.0000000000000609.
- 7. Chauhan A.K., Sharma D., Bisht M., Sah K. Malignant tumors of the nasal cavity: A clinicopathological study. Indian J Otolaryngol Head Neck Surg. 2014 Jan; 66 (Suppl 1): 84–89. doi:10.1007/s12070-011-0318-2.
- 8. Ho A.S., Ochoa A., Jayakumaran G., et al. Molecular changes associated with distant metastasis in adenoid cystic carcinoma of the salivary glands. JAMA Oncol. 2019 Jan; 5(1): 122-128. doi:10.1001/jamaoncol.2018.3534.
Data Sharing Statement
There are no additional data available.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
Information not provide.
Conflicts of Interest
The authors report no conflicts of interest in this work.
About this article
Cite this article
Pradumn Mishra, Rishabh Mahajan, Nayantara Pitaliya, et al. Advanced Adenoid Cystic Carcinoma with Widespread Visceral and Skeletal Metastases. Ind J Canc Educ Res 2025; 13(2): 89-92.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| August 28, 2025 | October 29, 2025 | December 30, 2025 |
DOI: https://doi.org/10.21088/ijcer.2321.9815.13225.6
Keywords
Adenoid cystic carcinomaMetastatic ACCTargeted therapyVEGF inhibitorsPalliative radiotherapySearch for Similar Articles
Similar Articles
- Current Therapeutic Strategies Targeting Tyrosine Kinase Receptor in Colon Canc...
- Colonic Adenocarcinoma with Coexisting Amoebiasis
- Long-Term Survival and Toxicity in Medically Inoperable Carcinoma Esophagus Foll...
- A Prospective Analytical Study of Pulmonary Toxicity Following Postmastectectomy...
- Cancer Incidence in Rajasthan Based, on Real Time ICD Coded Data, of a Leading C...
Article Level Metrics
Last UpdatedWednesday 17 June 2026, 14:51:18 (IST)
862
Accesses
9
248
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | August 28, 2025 |
| Accepted | October 29, 2025 |
| Published | December 30, 2025 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
